参考文献/References:
[1]Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin,2018,68(6):394-424.
[2]Turashvili G,Park KJ. Cervical glandular neoplasia: classification and staging.Surg Pathol Clin,2019,12(2):281-313.
[3]Kojima A, Mikami Y, Sudo T, et al. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix.Am J Surg Pathol, 2007,31(5):664-672.
[4]Kurman RJ. International Agency for Research on Cancer,World Health Organization. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon: International Agency for Research on Cancer,2014.183-194.
[5]Karamurzin YS, Kiyokawa T, Parkash V, et al. Gastrictype endocervical adenocarcinoma: An aggressive tumor with unusual metastatic patterns and poor prognosis.Am J Surg Pathol,2015,39(11):1449-1457.
[6]Huang YT, Wang CC, Tsai CS, et al. Longterm outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definitive radiotherapy.Int J Radiat Oncol Biol Phys,2011,80(2):429-436.
[7]Kuragaki C, Enomoto T, Ueno Y, et al. Mutations in the STK11 gene characterize minimal deviation adenocarcinoma of the uterine cervix.Lab Invest,2003,83(1):35-45.
[8]宗丽菊,成宁海,张明,等.PeutzJeghers综合征伴子宫颈腺癌二例并文献复习.中华妇产科杂志,2018,53(9):630-632.
[9]Rajendran S, Hussein Y, Park KJ, et al. Fallopian tube mucosal involvement in cervical gastrictype adenocarcinomas: Report of a series with discussion of the distinction from synchronous in situ tubal lesions.Am J Surg Pathol,2018,42(6):813-820.
[10]Talia KL, McCluggage WG. The developing spectrum of gastrictype cervical glandular lesions.Pathology,2018,50(2):122-133.
[11]Nakamura A, Yamaguchi K, Minamiguchi S, et al. Mucinous adenocarcinoma, gastric type of the uterine cervix: clinical features and HER2 amplification.Med Mol Morphol,2019,52(1):52-59.
[12]Kido A, Mikami Y, Koyama T, et al. Magnetic resonance appearance of gastrictype adenocarcinoma of the uterine cervix in comparison with that of usualtype endocervical adenocarcinoma: a pitfall of newly described unusual subtype of endocervical adenocarcinoma.Int J Gynecol Cancer,2014,24(8):1474-1479.
[13]Nicolet V, Carignan L, Bourdon F, et al. MR imaging of cervical carcinoma: a practical staging approach.Radiographics,2000,20(6):1539-1549.
[14]孙睿,罗成燕,姜旖,等.5例宫颈胃型黏液性癌的临床、影像和病理分析并文献复习.现代妇产科进展,2018,27(10):730-734.
[15]Lee SH, Cho YJ, Cho KJ, et al. Effect of tibolone on the survival of early stage cervical adenocarcinoma patients.Obstet Gynecol Sci,2018,61(5):584-589.
[16]Hu K, Wang W, Liu X, et al. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy.Radiat Oncol,2018,13(1):249.
[17]Kojima A, Shimada M, Mikami Y, et al. Chemoresistance of gastrictype mucinous carcinoma of the uterine cervix: A study of the Sankai Gynecology Study Group.Int J Gynecol Cancer,2018,28(1):99-106.
[18]Singh RB, Chander S, Mohanti BK, et al. Neoadjuvant chemotherapy with weekly paclitaxel and carboplatin followed by chemoradiation in locally advanced cervical carcinoma: a pilot study.Gynecol Oncol,2013,129(1):124-128.
[19]Kumar L, Gupta S. Integrating chemotherapy in the management of cervical cancer: A critical appraisal. Oncology,2016,91(Suppl 1):S8-S17.